Cargando…

Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients

This study is conducted to investigate efficacy of an insulin jet injector and an insulin pen in treatment of type 2 diabetic patients. Sixty patients with type 2 diabetes were treated with rapid-acting insulin (regular insulin) and insulin analog (insulin aspart) using the jet injector and the pen...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lixin, Xiao, Xinhua, Sun, Xue, Qi, Cuijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228650/
https://www.ncbi.nlm.nih.gov/pubmed/28072690
http://dx.doi.org/10.1097/MD.0000000000005482
_version_ 1782493980205776896
author Guo, Lixin
Xiao, Xinhua
Sun, Xue
Qi, Cuijuan
author_facet Guo, Lixin
Xiao, Xinhua
Sun, Xue
Qi, Cuijuan
author_sort Guo, Lixin
collection PubMed
description This study is conducted to investigate efficacy of an insulin jet injector and an insulin pen in treatment of type 2 diabetic patients. Sixty patients with type 2 diabetes were treated with rapid-acting insulin (regular insulin) and insulin analog (insulin aspart) using the jet injector and the pen in 4 successive test cycles. Postprandial glucose and insulin concentrations in blood were measured over time. Areas under curves of glucose and the insulin were calculated, and efficacy of 2 injection methods in treatment of the diabetes was compared. Regular insulin and insulin aspart administration by the jet injector showed significant decreases in plasma glucose levels as compared to the pen injection (P < 0.05). Postprandial plasma glucose excursions at the time points of 0.5 to 3 hours were obviously lower in the jet-treated patients than the pen-treated ones (P < 0.05). Postprandial plasma insulin levels were markedly higher in the jet-treated patients than the pen-treated ones (P < 0.05). Area under the glucose curve in the pen-treated patients was significantly increased as compared to the jet-treated ones (P < 0.01). Efficacy of the insulin jet injector in treatment of type 2 diabetic patients is obviously superior to the insulin pen in regulating plasma glucose and insulin levels.
format Online
Article
Text
id pubmed-5228650
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-52286502017-01-25 Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients Guo, Lixin Xiao, Xinhua Sun, Xue Qi, Cuijuan Medicine (Baltimore) 4300 This study is conducted to investigate efficacy of an insulin jet injector and an insulin pen in treatment of type 2 diabetic patients. Sixty patients with type 2 diabetes were treated with rapid-acting insulin (regular insulin) and insulin analog (insulin aspart) using the jet injector and the pen in 4 successive test cycles. Postprandial glucose and insulin concentrations in blood were measured over time. Areas under curves of glucose and the insulin were calculated, and efficacy of 2 injection methods in treatment of the diabetes was compared. Regular insulin and insulin aspart administration by the jet injector showed significant decreases in plasma glucose levels as compared to the pen injection (P < 0.05). Postprandial plasma glucose excursions at the time points of 0.5 to 3 hours were obviously lower in the jet-treated patients than the pen-treated ones (P < 0.05). Postprandial plasma insulin levels were markedly higher in the jet-treated patients than the pen-treated ones (P < 0.05). Area under the glucose curve in the pen-treated patients was significantly increased as compared to the jet-treated ones (P < 0.01). Efficacy of the insulin jet injector in treatment of type 2 diabetic patients is obviously superior to the insulin pen in regulating plasma glucose and insulin levels. Wolters Kluwer Health 2017-01-10 /pmc/articles/PMC5228650/ /pubmed/28072690 http://dx.doi.org/10.1097/MD.0000000000005482 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 4300
Guo, Lixin
Xiao, Xinhua
Sun, Xue
Qi, Cuijuan
Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients
title Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients
title_full Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients
title_fullStr Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients
title_full_unstemmed Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients
title_short Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients
title_sort comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228650/
https://www.ncbi.nlm.nih.gov/pubmed/28072690
http://dx.doi.org/10.1097/MD.0000000000005482
work_keys_str_mv AT guolixin comparisonofjetinjectorandinsulinpenincontrollingplasmaglucoseandinsulinconcentrationsintype2diabeticpatients
AT xiaoxinhua comparisonofjetinjectorandinsulinpenincontrollingplasmaglucoseandinsulinconcentrationsintype2diabeticpatients
AT sunxue comparisonofjetinjectorandinsulinpenincontrollingplasmaglucoseandinsulinconcentrationsintype2diabeticpatients
AT qicuijuan comparisonofjetinjectorandinsulinpenincontrollingplasmaglucoseandinsulinconcentrationsintype2diabeticpatients